State Street Corp Mirum Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,381,627 shares of MIRM stock, worth $70 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,381,627

Previous 1,793,728 22.97%

Holding current value

$70 Million

Previous $70 Million 18.33%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$37.85 - $46.65 $15.6 Million - $19.2 Million	-412,101 Reduced 22.97%	1,381,627 $57.1 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $10 Million - $13.3 Million	297,511 Added 19.88%	1,793,728 $70 Million
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $31.3 Million - $46.2 Million	-1,326,255 Reduced 46.99%	1,496,217 $51.2 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $27.1 Million - $32.7 Million	1,087,697 Added 62.7%	2,822,472 $70.9 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $3.09 Million - $3.98 Million	113,865 Added 7.02%	1,734,775 $51.2 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $3.12 Million - $4.16 Million	126,493 Added 8.46%	1,620,910 $51.2 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $7.62 Million - $9.75 Million	323,992 Added 27.68%	1,494,417 $38.7 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $11.3 Million - $14.2 Million	-588,193 Reduced 33.45%	1,170,425 $28.1 Million
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $13.5 Million - $18.3 Million	769,656 Added 77.82%	1,758,618 $34.3 Million
Q3 2022 Nov 15, 2022	BUY	$19.98 - $29.44 $14.2 Million - $21 Million	713,095 Added 258.49%	988,962 $20.8 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $2.64 Million - $3.94 Million	143,123 Added 107.82%	275,867 $5.37 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $139,639 - $215,585	9,009 Added 7.28%	132,744 $2.92 Million
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $43,769 - $64,899	-3,354 Reduced 2.64%	123,735 $1.97 Million
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $18,176 - $26,294	1,303 Added 1.04%	127,089 $2.53 Million
Q2 2021 Aug 16, 2021	BUY	$15.84 - $20.6 $557,061 - $724,460	35,168 Added 38.81%	125,786 $2.18 Million
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $71,676 - $96,448	-4,400 Reduced 4.63%	90,618 $1.8 Million
Q4 2020 Feb 16, 2021	SELL	$15.75 - $25.45 $122,613 - $198,128	-7,785 Reduced 7.57%	95,018 $1.66 Million
Q3 2020 Nov 10, 2020	BUY	$18.4 - $26.59 $131,523 - $190,065	7,148 Added 7.47%	102,803 $1.98 Million
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $522,864 - $952,604	45,427 Added 90.44%	95,655 $1.86 Million
Q1 2020 May 11, 2020	BUY	$9.38 - $23.79 $471,138 - $1.19 Million	50,228 New	50,228 $703,000

Others Institutions Holding MIRM

# of Institutions

201

Shares Held

54.7M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.86B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Mirum Pharmaceuticals, Inc. Transaction History